siRNA, Anti-MEDAG, 2'-F/2'-OMe/2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT51144WQ-2OMe)

The product SIRGT51144WQ-2OMe is a type of small interfering RNA (siRNA) that targets MEDAG gene and regulates the expression of gene. The siRNA interferes with the expression of MEDAG gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_032849.3
Alternative Names AWMS3; C13orf33; MEDA-4; MEDA4; hAWMS3
Related Diseases Intraventricular Meningioma
Purification HPLC
Target Gene
Gene ID 84935
Uniprot ID Q5VYS4
Sub Cat Target Species Modification Scale  
SIRGT52144WQ-2F MEDAG Human 2ʹ-deoxy-2ʹ-fluoro (2'-F) Inquiry
SIRGT53144WQ-2MOE MEDAG Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT54144WQ-LNA MEDAG Human Locked Nucleic Acid (LNA) Inquiry
SIRGT51144WQ-RB MEDAG Human Ribo-modified Inquiry
SIRGT52144WQ-BB MEDAG Human Backbone-modified Inquiry

Related Products